Literature DB >> 3318708

Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature.

K C Smith1, M R Pittelkow, W P Su.   

Abstract

Panniculitis associated with homozygous severe alpha 1-antitrypsin deficiency was documented in three women hospitalized for painful cutaneous and subcutaneous ulcerations (severe panniculitis with spontaneous ulceration and drainage of clear or serosanguineous fluid). None had a history of trauma or infection. One patient responded rapidly and completely to treatment with dapsone. One patient, who had more extensive disease, failed to respond to prednisone plus dapsone; infusions of alpha 1-proteinase inhibitor concentrate led to resolution of her panniculitis. One patient who had severe and extensive panniculitis and pleural effusions failed to respond to corticosteroids but did well when both dapsone and infusions of alpha 1-proteinase inhibitor concentrate were added to her treatment program.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318708

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

Review 1.  Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.

Authors:  Ignacio Blanco; Beatriz Lara; Frederick de Serres
Journal:  Orphanet J Rare Dis       Date:  2011-04-12       Impact factor: 4.123

2.  New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy.

Authors:  B Gross; M Grebe; M Wencker; J K Stoller; L M Bjursten; S Janciauskiene
Journal:  Dermatology       Date:  2009-02-16       Impact factor: 5.366

Review 3.  Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history.

Authors:  M Needham; R A Stockley
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

4.  Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.

Authors:  J W Hay; E D Robin
Journal:  Am J Public Health       Date:  1991-04       Impact factor: 9.308

Review 5.  alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency.

Authors:  R A Sandhaus
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

6.  Alpha-1-antitrypsin deficiency panniculitis.

Authors:  C Irvine; V Neild; C Stephens; M Black
Journal:  J R Soc Med       Date:  1990-11       Impact factor: 18.000

7.  Idiopathic pleural panniculitis with recurrent pleural effusion not associated with Weber-Christian disease.

Authors:  Paolo Laperuta; Filomena Napolitano; Rosa Maria Di Crescenzo; Pio Zeppa; Antonio Galderisi; Carmine Selleri; Alessandro Vatrella; Mario Capunzo; Vincenzo Giuseppe Di Crescenzo
Journal:  Open Med (Wars)       Date:  2016-11-19

8.  A patient with Pfeifer-Weber-Christian disease--successful therapy with cyclosporin A: case report.

Authors:  Georg Pongratz; Boris Ehrenstein; Wolfgang Hartung; Jürgen Schölmerich; Martin Fleck
Journal:  BMC Musculoskelet Disord       Date:  2010-01-27       Impact factor: 2.362

Review 9.  The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.

Authors:  Danielle M Dunlea; Laura T Fee; Thomas McEnery; Noel G McElvaney; Emer P Reeves
Journal:  J Inflamm Res       Date:  2018-03-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.